Provider review, September 2026
CoraDoc prices three peptides individually, in four and ten-week blocks with the block length printed beside each figure. A countdown sale banner on the same page quotes different prices for both weight-loss molecules than the programme cards do, and the sale carried a hard end date one day after this reading, so every figure here is perishable.
CoraDoc is not a paid partner; this link may earn a commission if that changes. Full disclosure.
A persistent navigation strip advertises a sale on both weight-loss molecules. The programme cards further down the same page price both of them higher.
Both sets of figures are recorded here and neither is corrected, because the seller has not corrected either.
The banner also names a hard end date — one day after this record was made — which means the cheaper pair of figures is designed to expire, and a reader arriving later should expect the card prices instead.
Its NAD+ product is sold as a four-week block; its sermorelin and glutathione products are sold as ten-week blocks.
Each figure is recorded here as a non-monthly price for exactly that reason. A four-week block is not a month and a ten-week block is not two and a half of them.
The peptides carry brand names rather than molecule names, but each one states the tracked compound inside it, so they are filed against the compound. A multi-ingredient product on the same page is not filed at all.
The peptide page carries a starting figure covering its whole menu, presented as a single number for the category.
That figure is not recorded against any compound here, because a floor for a menu tells a reader nothing about the item they came for.
The three peptide figures that are recorded come from the products' own cards, where the block length is printed beside the number.
It states plainly that compounded semaglutide and compounded tirzepatide "are not FDA-approved as finished drug products and are not reviewed by the FDA" for safety or effectiveness.
It says it is "LegitScript certified" and works with "State Board of Pharmacy-licensed compounding pharmacies" and, where applicable, registered outsourcing facilities — a description of a class, with no individual pharmacy named and no certificate of analysis reachable. Its own marketing superlative, that it is "One of the Nation's Most Affordable LegitScript-Certified GLP-1 Programs", is quoted here rather than endorsed.
Its terms usefully disclaim a similarly named firm, stating that CoraDoc "is an independent telehealth company and is not affiliated with… CoraDoc Health, Inc." Its nationwide coverage line, by contrast, is prose with no state list behind it, and mentions Hawaii oddly on its own, so no coverage claim is credited.
Trellis Vitality frames its program around body-composition tracking rather than scale weight, pairing NAD+, glutathione and tesamorelin with at-home biomarker panels and a 90-day re-test, and names its dispensing pharmacy, VialsRX in Houston, by address.
Read the full Trellis Vitality review
Trellis Vitality is not a paid partner; this link may earn a commission if that changes. Full disclosure.
Visit Trellis VitalityThe site prints two. A sale banner quotes one pair of figures and the programme cards quote a higher pair, and the seller does not reconcile them. The banner named an end date one day after this reading.
Four weeks for its NAD+ product and ten weeks for its sermorelin and glutathione products. None of the three is sold by the month.
It says it is LegitScript certified and works with state-licensed compounding pharmacies. That is a claim about certification, not a test document; no certificate of analysis is reachable.
No, and it says so itself. Its terms state that it is an independent telehealth company not affiliated with the similarly named firm.
CoraDoc is not a paid partner; this link may earn a commission if that changes. Full disclosure.